Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator:A Cross-Sectional Analysis

INTRODUCTION: Clinical trials, although academically accepted as the most effective treatment available for cancer patients, poor accrual to clinical trials remains a significant problem. A clinical trials navigator (CTN) program was piloted where patients and/or their healthcare professionals could...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamm, Caroline, Cavallo-Medved, Dora, Moudgil, Devinder, McGrath, Lee, Huang, John, Li, Yueyang, Stratton, Tyler W., Robinson, Tyler, Naccarato, Krista, Sundquist, Stephen, Dancey, Janet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520135/
https://www.ncbi.nlm.nih.gov/pubmed/36165718
http://dx.doi.org/10.1177/10732748221130164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520135/
https://www.ncbi.nlm.nih.gov/pubmed/36165718
http://dx.doi.org/10.1177/10732748221130164

Ejemplares similares